These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 18641556
21. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients. Akbas SH, Yavuz A, Tuncer M, Yurdakonar E, Akcit F, Gurkan A, Demirbas A, Gultekin M, Ersoy F, Akaydin M. Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308 [Abstract] [Full Text] [Related]
22. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients. Barten MJ, Rahmel A, Garbade J, Bold A, Bittner HB, Dhein S, Mohr FW, Gummert JF. Transplant Proc; 2005 Dec; 37(10):4532-4. PubMed ID: 16387162 [Abstract] [Full Text] [Related]
25. Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors. Bardet V, Junior AP, Coste J, Lecoq-Lafon C, Chouzenoux S, Bernard D, Soubrane O, Lacombe C, Calmus Y, Conti F. Liver Transpl; 2006 Nov; 12(11):1649-54. PubMed ID: 17058250 [Abstract] [Full Text] [Related]
28. Initial liver graft function is a reliable predictor of tacrolimus trough levels during the first post-transplant week. Lock JF, Malinowski M, Schwabauer E, Martus P, Pratschke J, Seehofer D, Puhl G, Neuhaus P, Stockmann M. Clin Transplant; 2011 Nov; 25(3):436-43. PubMed ID: 20482563 [Abstract] [Full Text] [Related]
29. Circadian and time-dependent variability in tacrolimus pharmacokinetics. Park SI, Felipe CR, Pinheiro-Machado PG, Garcia R, Tedesco-Silva H, Medina-Pestana JO. Fundam Clin Pharmacol; 2007 Apr; 21(2):191-7. PubMed ID: 17391292 [Abstract] [Full Text] [Related]
31. Interindividual variation of maximal blood levels of tacrolimus after its oral administration in hematopoietic cell transplant recipients. Yamazaki R, Mori T, Aisa Y, Kato J, Nakamura Y, Nakazato T, Mihara A, Ikeda Y, Okamoto S. Transplant Proc; 2009 Jun; 41(5):1831-3. PubMed ID: 19545738 [Abstract] [Full Text] [Related]
32. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring. Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP. Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963 [Abstract] [Full Text] [Related]
33. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients. Fukudo M, Yano I, Yoshimura A, Masuda S, Uesugi M, Hosohata K, Katsura T, Ogura Y, Oike F, Takada Y, Uemoto S, Inui K. Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564 [Abstract] [Full Text] [Related]
37. Change in oral absorption of tacrolimus in a liver transplant recipient after reversal of jejunoileal bypass: case report. Kelley M, Jain A, Kashyap R, Orloff M, Abt P, Wrobble K, Venkataramanan R, Bozorgzadeh A. Transplant Proc; 2005 Sep; 37(7):3165-7. PubMed ID: 16213338 [Abstract] [Full Text] [Related]
38. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Wallemacq P, Armstrong VW, Brunet M, Haufroid V, Holt DW, Johnston A, Kuypers D, Le Meur Y, Marquet P, Oellerich M, Thervet E, Toenshoff B, Undre N, Weber LT, Westley IS, Mourad M. Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031 [Abstract] [Full Text] [Related]